Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
The Journal of General Virology|October 12, 2012
Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancerEric Hastie, Valery Z GrdzelishviliCurrent Opinion in Virology|February 21, 2015
Evolution of oncolytic virusesRafael Sanjuán, Valery Z GrdzelishviliJournal of Virology|December 5, 2008
Identification of sendai virus L protein amino acid residues affecting viral mRNA cap methylationAndrea M Murphy, Valery Z GrdzelishviliThe Journal of General Virology|November 17, 2017
Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year updateSébastien A Felt, Valery Z GrdzelishviliMolecular Therapy Oncolytics|May 9, 2017
Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene TherapyChristian Bressy, Eric Hastie, Valery Z GrdzelishviliPlos One|June 29, 2010
Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirinNirav R Shah, Amanda Sunderland, Valery Z GrdzelishviliCurrent Oncology (Toronto, Ont.)|November 26, 2025
Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Recent Progress and Emerging TrendsCassandra Catacalos-Goad, Charlotte Johnstone, Valery Z GrdzelishviliJournal of Virology|June 2, 2017
Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis VirusSébastien A Felt, Gaith N Droby, Valery Z GrdzelishviliVirology|May 13, 2015
An unexpected inhibition of antiviral signaling by virus-encoded tumor suppressor p53 in pancreatic cancer cellsEric Hastie, Marcela Cataldi, Nury Steuerwald, et al.Cancers|April 3, 2021
Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and SolutionsMolly C Holbrook, Dakota W Goad, Valery Z GrdzelishviliPageof 4